STOCK TITAN

Waters Corp - WAT STOCK NEWS

Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.

Waters Corporation (NYSE: WAT) is a global leader in the field of analytical instruments and software solutions. For nearly six decades, the company has pioneered advancements in chromatography, mass spectrometry, and thermal analysis, catering to life, materials, and food sciences. Headquartered in Milford, Massachusetts, Waters Corp. operates directly in 35 countries, supported by approximately 8,000 employees and 15 manufacturing facilities globally.

Waters' main business segments include Waters, TA Instruments, VICAM, ERA, and Nonlinear Dynamics. The company's diverse product portfolio features ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), chromatography columns, mass spectrometry systems, and laboratory informatics solutions. These innovations empower laboratory-dependent organizations to achieve advancements in healthcare, environmental management, food safety, and water quality.

Waters Corporation serves a wide array of customers, including biopharmaceutical companies (57% of sales), industrial clients (31% of sales), and academic/government institutions (12% of sales). The company’s products are available in over 100 countries, ensuring a broad market reach.

Recent achievements include the launch of new accessories for TA Instruments Discovery Hybrid Rheometers, designed for battery formulation analysis, and the introduction of Oasis WAX/GCB and GCB/WAX Cartridges for PFAS analysis. These innovations reflect the company’s commitment to addressing emerging scientific challenges and regulatory requirements. Additionally, Waters continues to enhance its mass spectrometry capabilities with products like the ACQUITY QDa II Mass Detector and the Xevo MRT MS, aimed at accelerating research in pharmaceuticals, food, chemicals, and materials.

Financially, Waters Corporation reported first-quarter 2024 sales of $637 million, with a strategic focus on innovation and operational efficiency. Despite a 7% decrease in sales compared to the previous year, the company remains optimistic about future growth, driven by new product launches and higher growth areas.

Waters Corporation stands as a pivotal player in the analytical instruments industry, consistently driving scientific advancements and operational excellence.

Rhea-AI Summary

Waters Corporation (NYSE:WAT) will have its SVP & Chief Financial Officer, Amol Chaubal, participate in a virtual fireside chat at Citi’s 2022 Virtual Healthcare Conference on February 24 at 3:30 PM ET. Investors can access the live webcast through Waters’ investor relations website, with a replay available for 30 days. Waters Corporation is recognized for pioneering innovations in chromatography, mass spectrometry, and thermal analysis, serving various sectors for over 60 years, and operates in 35 countries with more than 7,400 employees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) has acquired technology assets and intellectual property from Megadalton Solutions, enhancing its capabilities in Charge Detection Mass Spectrometry (CDMS). This acquisition allows Waters to overcome the limitations of traditional mass spectrometry, particularly in analyzing large proteins used in cell and gene therapies. The integration of CDMS technology is expected to expand Waters' product offerings and attract new customers in the biopharmaceutical sector, potentially boosting revenue from next-generation biologics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
-
Rhea-AI Summary

Waters Corporation (NYSE: WAT) reported fourth quarter 2021 sales of $836 million, an increase of 6% as reported and 8% in constant currency from $787 million in Q4 2020. GAAP EPS rose to $3.52 from $3.49. Full-year sales reached $2,786 million, an 18% increase, with GAAP EPS at $11.17, up from $8.36. Despite ongoing pandemic challenges, strong growth was seen across biopharma and industrial sectors. The company expects 2022 sales growth of 5% to 7% and non-GAAP EPS of $11.75 to $12.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE: WAT) announced that the U.S. FDA has expanded its use of Waters' Empower Chromatography Data Software and added NuGenesis Laboratory Management Software to support pharmaceutical testing. This transition to a common data management platform across five labs will enhance data retrieval and compliance with legislative mandates. Both software solutions will improve operational efficiencies for the FDA, allowing better management of analytical data vital for public health and safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) will live webcast its Q4 2021 financial results conference call on February 1, 2022, at 8:00 a.m. ET. Investors can access the presentation via Waters’ investor relations website. A replay will be available until February 15, 2022, at midnight ET. Waters, a leader in specialty measurement, has over 7,400 employees globally and operates in 35 countries, emphasizing innovations in chromatography and mass spectrometry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
Rhea-AI Summary

Waters Corporation (NYSE:WAT) has expanded its waters_connect informatics platform to support tandem quadrupole mass spectrometers with the new MS Quan application. This software enhances quantitative analysis by cutting data review time by up to 50% and facilitating compliance and data integrity. It streamlines the processing of large sample sets and enables accurate results in a secure manner. The MS Quan app is now globally available as an upgrade for select Waters' mass spectrometers, aiding laboratories in analyzing food and environmental samples effectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) will present at the J.P. Morgan Healthcare Conference on January 10, 2022, at 8:15 AM EST. Udit Batra, Ph.D., President and CEO, will address the investment community virtually. Interested investors can access the live webcast through Waters’ investor relations website, with a replay available for 30 days. Waters has led innovations in chromatography and mass spectrometry for over 60 years, operating in 35 countries and employing over 7,400 individuals worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.32%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., President and CEO, will present at the Evercore ISI 4th Annual HealthCONx Healthcare Conference on November 30, 2021, at 12:10 PM EST. Investors can access the live webcast on the company's investor relations website, with a replay available for 90 days. Founded over 60 years ago, Waters is a leader in specialty measurement, including chromatography and mass spectrometry, with operations in 35 countries and products available in over 100 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.66%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.66%
Tags
covid-19

FAQ

What is the current stock price of Waters (WAT)?

The current stock price of Waters (WAT) is $378.16 as of November 25, 2024.

What is the market cap of Waters (WAT)?

The market cap of Waters (WAT) is approximately 22.8B.

What industries does Waters Corporation serve?

Waters Corporation serves biopharmaceutical, industrial, and academic/government sectors, providing analytical instruments and software solutions.

What are some of Waters Corporation's recent product launches?

Recent launches include the ACQUITY QDa II Mass Detector, Xevo MRT MS, and Oasis WAX/GCB Cartridges for PFAS analysis.

How does Waters Corporation contribute to scientific advancements?

Waters Corporation pioneers innovations in chromatography, mass spectrometry, and thermal analysis, enabling significant progress in healthcare, environmental management, food safety, and water quality.

What is the significance of the TA Instruments Discovery Hybrid Rheometers?

These rheometers are designed to enable simultaneous electrical impedance and rheological measurements, critical for optimizing battery formulations.

How is Waters Corporation performing financially?

In the first quarter of 2024, Waters Corporation reported sales of $637 million, focusing on innovation and operational efficiency to drive future growth.

Where is Waters Corporation headquartered?

Waters Corporation is headquartered in Milford, Massachusetts, and operates directly in 35 countries.

How many employees does Waters Corporation have?

Waters Corporation employs approximately 8,000 people worldwide.

What are TA Instruments' main products?

TA Instruments specializes in thermal analysis and rheometry solutions, supporting advancements in various scientific fields.

What is the significance of the Oasis WAX/GCB Cartridges?

These cartridges streamline the sample preparation process for PFAS analysis, ensuring accuracy and reducing processing time.

How can I access Waters Corporation's financial results?

Waters Corporation's financial results can be accessed through their Investor Relations website, where live webcasts and replays of financial presentations are available.

Waters Corp

NYSE:WAT

WAT Rankings

WAT Stock Data

22.76B
59.34M
0.05%
96.88%
3.62%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
MILFORD